Advertisement

Osteosarcoma of the limb: An institutional report of 10 years experience with neoadjuvant chemotherapy and delayed surgery

  • A. Postma
  • W. A. Kamps
  • H. Schraffordt Koops
  • R. P. H. Veth
  • L. N. H. Göeken
  • W. M. Molenaar
Part of the Cancer Treatment and Research book series (CTAR, volume 62)

Abstract

Following the initial report of Rosen in 1976 [1], a study of preoperative chemotherapy for treatment for primary osteosarcoma patients was started in our hospital in 1978.

Keywords

Clin Oncol Preoperative Chemotherapy Limb Salvage Postoperative Chemotherapy Incomplete Treatment 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Rosen G, Murphy ML, Huvos AG, et al. Chemotherapy, en bloc resection and prosthetic bone replacement in the treatment of osteogenic sarcoma. Cancer 37:1–11, 1976.PubMedCrossRefGoogle Scholar
  2. 2.
    Rosen G, Caparros B, Huvos AG, et al. Preoperative chemotherapy for osteogenic sarcoma. Cancer 49:1221–1230, 1982.PubMedCrossRefGoogle Scholar
  3. 3.
    Rosen G, Marcone RC, Caparros B, et al. Primary osteogenic sarcoma. The rationale for preoperative chemotherapy and delayed surgery. Cancer 43:2163–2177, 1979.PubMedCrossRefGoogle Scholar
  4. 4.
    Ettinger LJ, Douglass HO, Higby DJ, et al. Adjuvant adriamycin (Adr) and cis-diammine dichloro-platinum (cis-platinum) in primary osteosarcoma. Cancer 47:248–254, 1981.PubMedCrossRefGoogle Scholar
  5. 5.
    Enneking WF. Modified system for functional evaluation of surgical management of musculoskeletal tumors. In: Limb Salvage in Musculoskeletal Oncology. Enneking WF, Ed. Churchill Livingstone, New York, pp 626–639, 1987.Google Scholar
  6. 6.
    Veth RPH, Graaf SSN de, Heeten GH den, et al. Epiphyseal fractures in children, treated with chemotherapy, tumor resection and endoprosthesis. J Surg Oncol 26: 40–46, 1984.PubMedCrossRefGoogle Scholar
  7. 7.
    Winkler K, Beron G, Delling G, et al. Neoadjuvant chemotherapy of osteosarcoma: result of a randomized cooperative trail (COSS-82) with salvage chemotherapy based on histological tumor response. J Clin Oncol 6:329–337, 1988.PubMedGoogle Scholar
  8. 8.
    Bacci G, Avella M, Capanna R, et al. Neoadjuvant chemotherapy in the treatment of osteosarcoma of the extremities: preliminary results in 131 cases treated preoperatively with methotrexate and cisdiammino platinum. Ital J Orthop Traum 14:23–29, 1988.Google Scholar
  9. 9.
    Prasad R, Bacci G, Campanacci M, Picci P. Does drug dose intensity (DDI) of chemotherapy (C) determine the prognosis of primary high grade osteosarcoma? Proc Am Soc Clin Oncol 9:311, (abstract 1202) 1990.Google Scholar
  10. 10.
    Miser J, Pritchard D, Sim F, et al. Treatment of osteosarcoma (OGS) with a new chemotherapeutic regimen of ifosfamide (Ifos), Adriamycin (ADR) and high dose methothrexate (HDMTX) (abstract 1143) Proc Am Soc Clin Oncol 9:295, 1990.Google Scholar
  11. 11.
    Rosen G. The current management of malignant bone tumors: where do we go from here? Med J Austr 148:373–377, 1988.Google Scholar

Copyright information

© Springer Science+Business Media New York 1993

Authors and Affiliations

  • A. Postma
    • 1
  • W. A. Kamps
    • 1
  • H. Schraffordt Koops
    • 1
  • R. P. H. Veth
    • 1
  • L. N. H. Göeken
    • 1
  • W. M. Molenaar
    • 1
  1. 1.Department of PediatricsUniversity HospitalGroningenThe Netherlands

Personalised recommendations